Clinical Trial Update: A LM-302 Combination With Other Anti-Tumor Therapies Phase ll Study [Phase 2]

View source ↗

Summary

Phase II clinical trial update for LM-302 in combination with other anti-tumor therapies, currently recruiting for digestive system neoplasms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Digestive System Neoplasms

Drugs mentioned

• LM-302

Snippet

Sponsor: LaNova Medicines Zhejiang Co., Ltd. | Conditions: Malignant Neoplasms of Digestive Organs | Phase 2 | Status: RECRUITING